Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective

OBJECTIVES: To evaluate the cost effectiveness of onabotulinumtoxinA (BOTOX(®), 200 units [200 U]) for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to subcervical spinal cord injury or multiple sclerosis that is not adequately managed with ant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacoeconomics
Hauptverfasser: Hamid, Rizwan, Loveman, Clara, Millen, Jim, Globe, Denise, Corbell, Catherine, Colayco, Danielle, Stanisic, Sanja, Gultyaev, Dmitry
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2014
Schlagworte:
Original Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381108/
https://ncbi.nlm.nih.gov/pubmed/25526842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-014-0245-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge